Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19

Daniel Clark Files, Frank Tacke, Alexandra O’Sullivan, Patrick Dorr, William G. Ferguson, William G. Powderly

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences